A synthetic peptide for use as a blocking control in assays to test for specificity of AHSG antibody, Alternative Names: AHSG control peptide, AHSG antibody Blocking Peptide, Anti-AHSG Blocking Peptide, Alpha-2-Hs-Glycoprotein Blocking Peptide, A2HS Blocking Peptide, AHS Blocking Peptide, FETUA Blocking Peptide, HSGA Blocking Peptide
Optimal conditions should be determined by the investigator
Beschränkungen
Nur für Forschungszwecke einsetzbar
Format
Lyophilized
Rekonstitution
Add 100 µL of distilled water for a final peptide concentration is 1 mg/mL.
Buffer
PBS
Handhabung
Avoid repeated freeze/thaw cycles.
Lagerung
-20 °C
Informationen zur Lagerung
Store at -20 °C long term.
Target
Fetuin A (AHSG)
(alpha-2-HS-Glycoprotein (AHSG))
Hintergrund
Alpha2-HS glycoprotein (AHSG), a glycoprotein present in the serum, is synthesized by hepatocytes. The AHSG molecule consists of two polypeptide chains, which are both cleaved from a proprotein encoded from a single mRNA. It is involved in several functions, such as endocytosis, brain development and the formation of bone tissue. However, its exact significance is still obscure.